# Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC

> **NCT01282658** · — · UNKNOWN · sponsor: **Huazhong University of Science and Technology** · enrollment: 200 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01282658
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2012-12
- **Final completion:** 2013-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01282658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01282658, "Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01282658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*